BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 14, 2016
View Archived Issues
FDA grants orphan drug designation for ATI-1501
Read More
Noveome debuts with topline data from phase I trials of ST-266
Read More
Karos Pharmaceuticals advances KAR-5585 into clinical development
Read More
Replikins tests trivalent Zika-Dengue-Japanese encephalitis vaccine candidate
Read More
Parker Institute for Cancer Immunotherapy established with USD 250 million grant
Read More
Phase I/II trial of TG-01 shows immune response with reduced number of vaccinations
Read More
European grant supports Orgenesis' work in type 1 diabetes
Read More
Lead Discovery Center and Merck KGaA disclose LMP7 inhibitors
Read More
Genentech and Roche describe BTK inhibitors
Read More
Korea Institute of Science and Technology patents MAO-B inhibitors
Read More
McGill University reports AR ligands
Read More
Riboscience divulges respiratory syncytial virus RNA replication inhibitors
Read More
Researchers present results from in vitro and in vivo studies of WCK-4282
Read More
QIAGEN and Mirati partner on companion diagnostic test for use with glesatinib
Read More
SIGA Technologies emerges from chapter 11 bankruptcy following court approval
Read More
Mul-1867 shows promising activity against multidrug-resistant Pseudomonas aeruginosa
Read More
Evaluating safety and pharmacokinetics in dose escalation of WCK-771 and WCK-2349
Read More
Intrexon establishes collaborations with startups backed by Harvest Intrexon Enterprise Fund
Read More
PDS Biotechnology completes phase I study for PDS-0101
Read More
Novel regulatory mutations may be associated with OTCD
Read More
FDA accepts sBLA and grants priority review for Keytruda in head and neck cancer
Read More
Vernalis completes CCP-08 bioavailability study
Read More
DNDi and Pharco Pharmaceuticals to test ravidasvir and sofosbuvir as affordable hepatitis C regimen
Read More
Wallenberg Foundation grants support work at Karolinska Institutet
Read More
New data from OpT2mise study support use of Medtronic's insulin pumps for type 2 diabetes
Read More